Company

Merida Biosciences

Biotechnology Research Cambridge, Massachusetts, United States 45 employees

Employees: 45
Contacts: 3
Emails: 3
Phones: 3

www.meridabio.com LinkedIn Crunchbase

Merida Biosciences Overview

Headquarters: Cambridge, Massachusetts, United States
Website: www.meridabio.com
Industry: Biotechnology Research
Employees: 45
Founded: 2022
Funding: 121.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

ensures we can move with speed and intention. We’re grateful for their support and excited for what’s ahead. Special thanks to our lab manager

About Merida Biosciences

Merida Biosciences is a biotechnology company pioneering a new class of precision therapeutics designed to selectively and durably eliminate pathogenic antibodies that drive disease. The company is advancing a robust pipeline to precisely eliminate the root cause of multiple autoimmune and allergic conditions that are inadequately treated today. Its lead program is designed to specifically and rapidly clear the pathogenic autoantibodies that cause Graves' disease, an autoimmune disorder that affects the thyroid gland. Merida was publicly launched in April 2025 and is based in Cambridge, MA. For more information about Merida, visit www.meridabio.com.

Merida Biosciences Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 3; 75.0% coverage

Merida Biosciences Org Chart

Sample employees and titles

Name	Title	Location	Contact
Adam Townsend	Chief Executive Officer Merida	Greater Boston, United States	Email Phone
Cristin Berkey	Biotech Attorney Focused on Early Stage		View
Denis Mandel	VP of Finance	United States	Email Phone
Reid Huber	Partner @ Third Rock Ventures	Boston, Massachusetts, United States	Email Phone